Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 25 January 2024
      Cardiovascular disease: LSE-report highlights life-saving potential of secondary prevention
 
 
Cardiovascular disease: LSE-report highlights life-saving potential of secondary... 23 January 2024
 

Cardiovascular disease (CVD) is the number one killer in Europe, but a new study by the London School of Economics and Political Science (LSE) shows the opportunity to save hundreds of thousands lives. The report, commissioned by EFPIA, features six recommendations that can reduce the risk of fatal heart attacks and strokes in people living with CVD, by following medical guidelines.

“There is a huge opportunity to address reversible risk factors in people who are already living with cardiovascular disease,” said Nathalie Moll, Director-General of EFPIA. “If existing evidence-based treatment targets and recommendations are followed, the impact will be profound.”

 

Read more →
 
 
      News
 
  23 January 2024 EFPIA response to the adoption of the EMA Fees Regulation

EFPIA welcomes the adoption of the EMA Fees regulation by the Council and the Parliament. 

Read more →
 
 
 
      Blogs
 
  22 January 2024 From theory to therapy – MSD Policy Passport on Pharmaceutical Innovation

Policy makers are in the driving seat. Their decisions play a key role in the creation and sustainability of Europe’s...

Read more →
 
 
 
      Events
 
 
26 JAN 2024
  Real-World data, Machine learning and Deep analytics in rare diseases Virtual event

EJP RD - European Joint Programme on Rare Diseases

Learn more →
 
 
 
08 FEB 2024
  ACCELERATE 2024 Paediatric Oncology Conference Brussels and virtually

Join us to advance paediatric oncology drug development.

Learn more →
 
 
 
20 FEB 2024
  Getting to the heart of the matter: improving cardiovascular health in Europe Virtual event

Join us to be at the forefront of shaping cardiovascular health management in the EU.

Learn more →
 
 
 
07 MAR 2024
  Digitally-enabled healthcare: Is our ecosystem on track? Brussels and online

Organised by the EU Health Coalition.

Learn more →
 
 
      We are hiring!

Join the EFPIA team! We have 3 positions open:
🔵 Assistant Manager Communications
🟣 Vaccines Europe EU Project Manager
🟢 Vaccines Europe Public Affairs Intern


Check our website for more details and apply now.

 
 
      What we are reading
Game-changing trial for children with tumours being established thanks to EU-PEARL 24 January 2024  (IHI) Read more →
Impact of the EU's General Pharmaceutical Legislation on Europe’s innovation ecosystem and... 24 January 2024  (Europabio) Read more →
Healthcare through patient's eyes: The next generation of healthcare performance indicators... 24 January 2024  (OECD) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe